Sen. Sanders Applauds AstraZeneca for Its Commitment to Extend $35 Cap to Any Future 'Green' Inhalers
December 14, 2024
December 14, 2024
WASHINGTON, Dec. 14 -- Sen. Bernie Sanders, I-Vermont, issued the following news release:
Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), today applauds AstraZeneca for its commitment to cap the cost of any future "green" inhalers at $35.
In January 2024, Sanders led the HELP Committee in launching an investigation into the four major manufacturers of inhalers and their efforts to keep prices far . . .
Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), today applauds AstraZeneca for its commitment to cap the cost of any future "green" inhalers at $35.
In January 2024, Sanders led the HELP Committee in launching an investigation into the four major manufacturers of inhalers and their efforts to keep prices far . . .